BDRX News and Press, Biodexa Pharmaceuticals PLC-ADR

July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024 After Only Two Infusions and Two Patients at Optimal Dose, Median Overall Survival Across all Patients was 16....

June 24, 2024 Biodexa Pharmaceuticals PLC Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapa™ at 12 months in Familial Adenomatous Polyposis (FAP) Overall 75% Non-progression Rate at 12 Months Median Decrease in Overall Polyp Burden at 12 Month...

13 June 2024 Biodexa Pharmaceuticals PLC (“ Biodexa ” or the “ Company ”) Results of Annual General Meeting Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline...

June 10, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona B...

2024-06-06 16:17:51 ET More on Biodexa Pharmaceuticals Biodexa rallies 80% on positive Phase 2 data for eRapa Biodexa shares rally 126% on rapamycin licensing deal Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals Read the full article on Seeki...

CARDIFF, UK / ACCESSWIRE / June 3, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) just announced promising phase 2 results for its newly in-licensed drug eRapa for treating familial adenomatous polyposis (FAP), a mainly genetic disease of the lower GI tract for which there is currently no reme...

2024-05-23 08:24:59 ET Losers: Barnes & Noble Education ( BNED ) -38% . MGO Global ( MGOL ) -29% . Cytokinetics CYTK -15% announces proposed offering of shares . VF Corp. VFC -13% after Q4 earnings release . Tango Therapeutics TNGX ...

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 33.8% to $0.0788 on volume of 1,221,538,672 shares Akoustis Technologies Inc. (AKTS) rose 128.8% to $0.3151 on volume of 536,119,838 shares Crown Electrokinetics Corp. (CRKN) rose 3.1% t...

A look at the top 10 most actives in the United States Akoustis Technologies Inc. (AKTS) rose 254.9% to $0.4887 on volume of 265,314,772 shares Greenwave Technology Solutions Inc. (GWAV) rose 2.9% to $0.0606 on volume of 147,993,224 shares Crown Electrokinetics Corp. (CRKN) fell 17.8% to ...

2024-05-22 08:55:00 ET More on Biodexa Pharmaceuticals Biodexa rallies 80% on positive Phase 2 data for eRapa Biodexa shares rally 126% on rapamycin licensing deal Read the full article on Seeking Alpha For further details see: Biodexa Pharmaceuticals rec...